TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T50688	Glycoprotein IIb/IIIa receptor	D09ZXO	Cilengitide	Phase 3	176873	C27H40N8O7	588.7	CC(C)[C@H]1C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N	IC50 = 206000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B01FCM	Ethyl 1-[4-[(5S)-5-[[(2-amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]-2-oxopiperidine-4-carboxylate;2,2,2-trifluoroacetic acid	Investigative	73350496	C24H26F3N5O8S	601.6	CCOC(=O)C1CCN(C(=O)C1)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B01RGZ	2-[1-[(2S)-2-[[4-(Diaminomethylideneamino)benzoyl]amino]propanoyl]piperidin-4-yl]acetic acid	Investigative	44306547	C18H25N5O4	375.4	C[C@@H](C(=O)N1CCC(CC1)CC(=O)O)NC(=O)C2=CC=C(C=C2)N=C(N)N	IC50 = 741310.24 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B03FSW	(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-Acetamido-3-(1H-imidazol-5-yl)propanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]acetyl]amino]propanoyl]amino]-6-aminohexanoyl]amino]-5-amino-5-oxopentanoyl]amino]propanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoic acid	Investigative	15088300	C52H82N18O17	1231.3	C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CN=CN2)NC(=O)C	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B0CJD2	16-Acetylamino-7-carbamoylmethyl-13-(3-guanidino-propyl)-3,3,14-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadecane-4-carboxylic acid amide	Investigative	73346997	C23H40N10O7S2	632.8	CC(=O)N[C@@H]1CSSC([C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](N(C1=O)C)CCCN=C(N)N)CC(=O)N)C(=O)N)(C)C	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B0I5LD	(3S)-3-[[2-[[(2S)-2-Acetamido-5-(carbamoylamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088303	C17H29N7O9	475.5	CC(=O)N[C@@H](CCCNC(=O)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B14HJM	Klerval	Investigative	44462165	C26H45N5O6	523.7	CCN(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CC1CCCCC1)C(=O)N)C(=O)CCCC2CCNCC2	IC50 > 2350000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B1ERF7	(3S)-3-[[(2S)-1-[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088306	C20H34N8O8	514.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B1GW7D	((S)-1-{2-[(4-Guanidinomethyl-cyclohexanecarbonyl)-amino]-acetyl}-3-oxo-4-phenethyl-piperazin-2-yl)-acetic acid	Investigative	10553451	C25H36N6O5	500.6	C1CC(CCC1CN=C(N)N)C(=O)NCC(=O)N2CCN(C(=O)[C@@H]2CC(=O)O)CCC3=CC=CC=C3	IC50 > 1000000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B1RQ0U	3-{[3-Oxo-2-(2-piperidin-4-yl-ethyl)-indane-5-carbonyl]-amino}-propionic acid	Investigative	22402471	C20H26N2O4	358.4	C1CNCCC1CCC2CC3=C(C2=O)C=C(C=C3)C(=O)NCCC(=O)O	IC50 = 2300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B1Z2BP	(S)-N-((S)-1-Carboxy-2-cyclohexyl-ethyl)-3-{2-[ethyl-(4-piperidin-4-yl-butyryl)-amino]-acetylamino}-succinamic acid	Investigative	9984308	C26H44N4O7	524.6	CCN(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1CCCCC1)C(=O)O)C(=O)CCCC2CCNCC2	IC50 = 1012000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B24EBN	Ethyl 2-[benzyl-[(2S)-2-[(4-carbamimidoylphenoxy)methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]amino]-2-oxoacetate;2,2,2-trifluoroacetic acid	Investigative	71654376	C29H28F3N3O8	603.5	CCOC(=O)C(=O)N(CC1=CC=CC=C1)C2=CC3=C(C=C2)O[C@H](CO3)COC4=CC=C(C=C4)C(=N)N.C(=O)(C(F)(F)F)O	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B28ELR	Ethyl 1-[4-[(5S)-5-[[(3-amino-4-chlorobenzoyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate	Investigative	71699203	C25H29ClN4O5	501	CCOC(=O)C1CCN(CC1)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC(=C(C=C4)Cl)N	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B2BWK6	3-{[6-(2-Piperidin-4-yl-ethylcarbamoyl)-pyridine-2-carbonyl]-amino}-propionic acid	Investigative	44297845	C17H24N4O4	348.4	C1CNCCC1CCNC(=O)C2=NC(=CC=C2)C(=O)NCCC(=O)O	IC50 = 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B39PJM	(S)-N-((R)-1-Carboxy-3-cyclohexyl-propyl)-3-{2-[ethyl-(4-piperidin-4-yl-butyryl)-amino]-acetylamino}-succinamic acid	Investigative	44462164	C27H46N4O7	538.7	CCN(CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](CCC1CCCCC1)C(=O)O)C(=O)CCCC2CCNCC2	IC50 = 1930000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B3B9ON	(3S)-3-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1-(ethylamino)-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088316	C19H34N8O8	502.5	CCNC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)C	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B3XK5O	[16-Acetylamino-4-carbamoyl-13-(4-guanidino-butyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid	Investigative	73350084	C23H39N9O8S2	633.7	CC(=O)N[C@@H]1CSSC([C@@H](NC(=O)[C@H](NC(=O)CNC(=O)[C@H](NC1=O)CCCCN=C(N)N)CC(=O)O)C(=O)N)(C)C	IC50 = 385000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B45NTB	Ethyl 1-[4-[(5S)-5-[[(2-amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]-3-methyl-2-oxopiperidine-3-carboxylate;2,2,2-trifluoroacetic acid	Investigative	73356536	C25H28F3N5O8S	615.6	CCOC(=O)C1(CCCN(C1=O)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N)C.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B4A8PD	(3S)-3-[[(2S)-2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	44336250	C18H32N8O8	488.5	C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)C	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B4RNU5	4-(2-Bromoacetamido)-TEMPO	Investigative	16211712	C11H20BrN2O2	292.19	CC1(CC(CC(N1[O])(C)C)NC(=O)CBr)C	Ki > 1000000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B4THC3	1-[(S)-2-[4-(Guanidinomethyl)benzoylamino]propionyl]piperidine-4-carboxylic acid	Investigative	44306543	C18H25N5O4	375.4	C[C@@H](C(=O)N1CCC(CC1)C(=O)O)NC(=O)C2=CC=C(C=C2)CN=C(N)N	IC50 = 707945.78 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B5Q7BV	Ethyl 2-[benzyl-[(2R)-2-[(4-carbamimidoylphenoxy)methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]amino]-2-oxoacetate;2,2,2-trifluoroacetic acid	Investigative	71654374	C29H28F3N3O8	603.5	CCOC(=O)C(=O)N(CC1=CC=CC=C1)C2=CC3=C(C=C2)O[C@@H](CO3)COC4=CC=C(C=C4)C(=N)N.C(=O)(C(F)(F)F)O	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B7AQX6	(2R)-2-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	44336210	C17H30N8O8	474.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(=O)N[C@@H](CO)C(=O)N)C(=O)O	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B7HGD4	[(4S,7S,13R,16S)-16-Acetylamino-4-carbamoyl-13-(3-guanidino-propyl)-3,3-dimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadec-7-yl]-acetic acid	Investigative	15088322	C22H37N9O8S2	619.7	CC(=O)N[C@@H]1CSSC([C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](NC1=O)CCCN=C(N)N)CC(=O)O)C(=O)N)(C)C	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B7PGR6	Ethyl 2-[benzyl-[(3R)-3-[(4-carbamimidoylphenoxy)methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]amino]-2-oxoacetate;2,2,2-trifluoroacetic acid	Investigative	71654530	C29H28F3N3O8	603.5	CCOC(=O)C(=O)N(CC1=CC=CC=C1)C2=CC3=C(C=C2)OC[C@H](O3)COC4=CC=C(C=C4)C(=N)N.C(=O)(C(F)(F)F)O	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B85FRU	(2S)-2-[[2-[[(2S)-2-[[(2S)-2-Amino-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]butanedioic acid	Investigative	90645591	C21H31N7O7	493.5	C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N	IC50 = 947000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B8A5KJ	(4S)-4-[[2-[[(2S)-2-Acetamido-6-aminohexanoyl]amino]acetyl]amino]-5-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid	Investigative	15088312	C18H32N6O8	460.5	CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B9FN4U	(2S)-2-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-N-[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]butanediamide	Investigative	15088308	C17H31N9O7	473.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	B9P5MB	1-[4-[(5S)-5-[[(5-Chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylic acid	Investigative	73348933	C21H22ClN3O5S	463.9	C1CN(CCC1C(=O)O)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BAX9K5	Ethyl 1-[4-[(5S)-5-[[(2-amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate;2,2,2-trifluoroacetic acid	Investigative	73356532	C24H28F3N5O7S	587.6	CCOC(=O)C1CCN(CC1)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BBA43I	3-{3-[(Piperidin-4-ylmethyl)-carbamoyl]-benzoylamino}-propionic acid	Investigative	19034178	C17H23N3O4	333.4	C1CNCCC1CNC(=O)C2=CC=CC(=C2)C(=O)NCCC(=O)O	IC50 = 330000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BC4J3T	(3S)-3-[[2-[[(2S)-2-Acetamido-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088304	C17H25N7O8	455.4	CC(=O)N[C@@H](CC1=CN=CN1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BD8W9J	2-Benzyloxycarbonylamino-3-[4-(3-phenyl-propoxy)-phenyl]-propionic acid	Investigative	10252306	C26H27NO5	433.5	C1=CC=C(C=C1)CCCOC2=CC=C(C=C2)C[C@@H](C(=O)O)NC(=O)OCC3=CC=CC=C3	IC50 > 1000000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BF58YL	Cyclo(Arg-Gly-Asp-D-Pro-Pro-Gly)	Investigative	15931147	C24H37N9O8	579.6	C1C[C@H]2C(=O)NCC(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=O)N3CCC[C@@H]3C(=O)N2C1)CC(=O)O)CCCN=C(N)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BF5J6Z	(S)-2-[((S)-3-Acetyl-thiazolidine-4-carbonyl)-amino]-3-[4-(2,6-dichloro-benzyloxy)-phenyl]-propionic acid	Investigative	9870468	C22H22Cl2N2O5S	497.4	CC(=O)N1CSC[C@@H]1C(=O)N[C@@H](CC2=CC=C(C=C2)OCC3=C(C=CC=C3Cl)Cl)C(=O)O	IC50 > 400000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BFQ12Y	Ethyl 1-[4-[(5R)-5-[[(3-amino-4-chlorobenzoyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate	Investigative	71699286	C25H29ClN4O5	501	CCOC(=O)C1CCN(CC1)C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC(=C(C=C4)Cl)N	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BHO2W5	(3S)-3-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]-methylamino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088307	C18H32N8O8	488.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)N(C)CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BIN80F	2-(2-{2-[2-(2-Amino-acetylamino)-5-guanidino-pentanoylamino]-acetylamino}-3-carboxy-propionylamino)-succinic acid	Investigative	44304954	C18H30N8O10	518.5	C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN)CN=C(N)N	IC50 > 500000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BJ2RX6	(3S)-3-[[2-[[(2R)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088298	C17H30N8O8	474.5	CC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BJF45Y	2-[5-[2-[[4-(1H-Benzimidazol-2-ylamino)cyclohexyl]methylamino]-2-oxoethyl]-6-oxo-11H-benzo[c][1]benzazepin-11-yl]acetic acid	Investigative	11757316	C32H33N5O4	551.6	C1CC(CCC1CNC(=O)CN2C3=CC=CC=C3C(C4=CC=CC=C4C2=O)CC(=O)O)NC5=NC6=CC=CC=C6N5	IC50 = 1000000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BJT93B	Ethyl 1-[4-[(5S)-5-[[(2-amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-3-carboxylate;2,2,2-trifluoroacetic acid	Investigative	73348935	C24H28F3N5O7S	587.6	CCOC(=O)C1CCCN(C1)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BK0LQ7	2-[5-[2-[[4-(1H-Benzimidazol-2-ylamino)phenyl]methylamino]-2-oxoethyl]-6-oxo-11H-benzo[c][1]benzazepin-11-yl]acetic acid	Investigative	10325138	C32H27N5O4	545.6	C1=CC=C2C(=C1)C(C3=CC=CC=C3N(C2=O)CC(=O)NCC4=CC=C(C=C4)NC5=NC6=CC=CC=C6N5)CC(=O)O	IC50 = 1000000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BKIL31	(3R)-3-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	71452640	C17H30N8O8	474.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BKOZ83	Ethyl 2-[benzyl-[(3S)-3-[(4-carbamimidoylphenoxy)methyl]-2,3-dihydro-1,4-benzodioxin-6-yl]amino]-2-oxoacetate;2,2,2-trifluoroacetic acid	Investigative	71654532	C29H28F3N3O8	603.5	CCOC(=O)C(=O)N(CC1=CC=CC=C1)C2=CC3=C(C=C2)OC[C@@H](O3)COC4=CC=C(C=C4)C(=N)N.C(=O)(C(F)(F)F)O	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BKPT81	1-[Methyl(4-guanidinobenzoyl)aminoacetyl]piperidine-4-acetic acid	Investigative	44306616	C18H25N5O4	375.4	CN(CC(=O)N1CCC(CC1)CC(=O)O)C(=O)C2=CC=C(C=C2)N=C(N)N	IC50 = 758577.58 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BL2SN3	3-{[1-Oxo-9-phenyl-2-(2-piperidin-4-yl-ethyl)-2,3,4,5-tetrahydro-1H-pyrrolo[1,2-a][1,4]diazepine-8-carbonyl]-amino}-propionic acid	Investigative	44362951	C25H32N4O4	452.5	C1CN2C=C(C(=C2C(=O)N(C1)CCC3CCNCC3)C4=CC=CC=C4)C(=O)NCCC(=O)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BM4GP8	Ethyl 1-[4-[(5R)-5-[[(2-amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylate;2,2,2-trifluoroacetic acid	Investigative	73347404	C24H28F3N5O7S	587.6	CCOC(=O)C1CCN(CC1)C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CN=C(S4)N.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BN1SF0	1-[4-[(5S)-5-[[(2-Amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-3-carboxylic acid;2,2,2-trifluoroacetic acid	Investigative	73353473	C22H24F3N5O7S	559.5	C1CC(CN(C1)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N)C(=O)O.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BNO21R	3-(4-Piperazin-1-yl-benzoylamino)-propionic acid	Investigative	44381942	C14H19N3O3	277.32	C1CN(CCN1)C2=CC=C(C=C2)C(=O)NCCC(=O)O	IC50 = 230000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BO94MR	Methyl 1-[2-[(4-carbamimidoylbenzoyl)-methylamino]acetyl]piperidine-4-carboxylate	Investigative	44382481	C18H24N4O4	360.4	CN(CC(=O)N1CCC(CC1)C(=O)OC)C(=O)C2=CC=C(C=C2)C(=N)N	IC50 = 331131.12 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BPHB48	3-[1-Oxo-6-(2-piperidin-4-yl-ethylcarbamoyl)-1,3-dihydro-isoindol-2-yl]-propionic acid	Investigative	44297814	C19H25N3O4	359.4	C1CNCCC1CCNC(=O)C2=CC3=C(CN(C3=O)CCC(=O)O)C=C2	IC50 = 10000000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BPX0N5	16-(2-Acetylamino-6-amino-hexanoylamino)-7-carboxymethyl-3,3,13-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadecane-4-carboxylic acid	Investigative	73353038	C25H41N7O10S2	663.8	C[C@H]1C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(SSC[C@@H](C(=O)N1)NC(=O)[C@H](CCCCN)NC(=O)C)(C)C)C(=O)O)CC(=O)O	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BPX43O	1-[4-[(5S)-5-[[(2-Amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]-3-methyl-2-oxopiperidine-3-carboxylic acid;2,2,2-trifluoroacetic acid	Investigative	73347406	C23H24F3N5O8S	587.5	CC1(CCCN(C1=O)C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N)C(=O)O.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BQ9G1M	(4S)-4-[[2-[[(2S)-2-Acetamido-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]-5-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-5-oxopentanoic acid	Investigative	15088309	C18H32N8O8	488.5	CC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BS0HG7	Ethyl 1-[4-[(5S)-5-[[(2-amino-1,3-thiazole-5-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-2-carboxylate;2,2,2-trifluoroacetic acid	Investigative	73353474	C24H28F3N5O7S	587.6	CCOC(=O)C1CCCCN1C2=CC=C(C=C2)N3C[C@@H](OC3=O)CNC(=O)C4=CN=C(S4)N.C(=O)(C(F)(F)F)O	IC50 > 300000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BSI42H	2-[(3S,6R,12R,15S,21S,24R,30R,33S)-3,21-Dibenzyl-24-(carboxymethyl)-12,30-bis[3-(diaminomethylideneamino)propyl]-2,5,8,11,14,20,23,26,29,32-decaoxo-1,4,7,10,13,19,22,25,28,31-decazatricyclo[31.3.0.015,19]hexatriacontan-6-yl]acetic acid	Investigative	44351621	C52H72N16O14	1145.2	C1C[C@H]2C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N3CCC[C@H]3C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](C(=O)N2C1)CC4=CC=CC=C4)CC(=O)O)CCCN=C(N)N)CC5=CC=CC=C5)CC(=O)O)CCCN=C(N)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BV12IU	1-[3-(4-Guanidinobenzoylamino)propionyl]piperidine-4-carboxylic acid	Investigative	44307296	C17H23N5O4	361.4	C1CN(CCC1C(=O)O)C(=O)CCNC(=O)C2=CC=C(C=C2)N=C(N)N	IC50 = 758577.58 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BWD4J9	Arginyl-glycyl-aspartyl-phenylalanine	Investigative	3080994	C21H31N7O7	493.5	C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N	IC50 = 725000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BWOU42	(3S)-3-[[2-[[(2S)-2-Acetamido-6-aminohexanoyl]amino]acetyl]amino]-4-[[(2S)-1-amino-3-hydroxy-1-oxopropan-2-yl]amino]-4-oxobutanoic acid	Investigative	15088302	C17H30N6O8	446.5	CC(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N	IC50 > 200000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BWSC75	3-{2-[2-(2-Acetylamino-acetylamino)-5-guanidino-pentanoylamino]-acetylamino}-N-(1-carbamoyl-2-methyl-propyl)-succinamic acid	Investigative	44304495	C21H37N9O8	543.6	CC(C)[C@@H](C(=O)N)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC(=O)C	IC50 > 500000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BWX8P9	(5S,8S)-3-[(S)-2-Carboxy-2-(2,4,6-trimethyl-benzenesulfonylamino)-ethylcarbamoyl]-8-(pyridin-2-ylaminomethyl)-1-oxa-2,7-diaza-spiro[4.4]non-2-ene-7-carboxylic acid benzyl ester	Investigative	44350342	C33H38N6O8S	678.8	CC1=CC(=C(C(=C1)C)S(=O)(=O)N[C@@H](CNC(=O)C2=NO[C@]3(C2)C[C@H](N(C3)C(=O)OCC4=CC=CC=C4)CNC5=CC=CC=N5)C(=O)O)C	IC50 > 1000000 nM	Non binder
T50688	Glycoprotein IIb/IIIa receptor	BX52SA	1-[4-[(5R)-5-[[(5-Chlorothiophene-2-carbonyl)amino]methyl]-2-oxo-1,3-oxazolidin-3-yl]phenyl]piperidine-4-carboxylic acid	Investigative	73347403	C21H22ClN3O5S	463.9	C1CN(CCC1C(=O)O)C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl	IC50 > 300000 nM	Non binder